Home > Archive > 2007 >

Volume 26, Number 3 (September)

Interventional Cardiology and the Patient With Type 2 Diabetes (pages 6-13)

Melanie Sulistio, M.D., Ramavathi Nandyala, M.D., Michael Lujan, B.S., Adrienne S. Zion, Ph.D., and Robert Chilton, D.O., F.A.C.C.

People with diabetes are three times more likely to have a cardiovascular event than those without diabetes. This article covers the mechanisms responsible for this disparity as well as assessment and optimal management strategies for the individual patient.
Complications and comorbiditiesCardiovascular disease

Fracture as a Consequence of Thiazolidinedione Treatment in Type 2 Diabetes (pages 14-21)

Larry J. Suva, Ph.D., and Ruth L. Thomas, M.D.

Drs. Suva and Thomas review the current understanding of the effect of thiazolidinediones on bone and provide some evidence-based answers to questions arising from the increased rate of fractures in Type 2 patients.
Drug treatmentThiazolidinediones

Can We "Drive Out" Obesity by Removing the Drive to Eat? (pages 22-28)

Aruna Venkatesh, M.D.

This article reviews the endocannabanoid system and the advances that have led to the development of endocannabanoid-receptor antagonists, as well as clinical trials using rimonabant for treating obesity in patients with dyslipidemia and diabetes.
Complications and comorbiditiesObesity

Diabetes and Recreational Scuba Diving (pages 30-32)

Neal W. Pollock, Ph.D.

People with diabetes who want to participate in recreational diving can, providing certain criteria are met. Dr. Pollock outlines the recent—and very clear—guidelines of the Undersea and Hyperbaric Medical Society and the Divers Alert Network.
Management strategies and toolsPhysical activity
Special activities with diabetesScuba diving

National Standards for Diabetes Self-Management Education (pages 33-35)

Martha M. Funnell, M.S., R.N., C.D.E.

Every five years, the diabetes community reviews these standards to ensure that they remain relevant and reflect available evidence. The author reviews the 2007 standards—in particular, significant changes in four areas.
Professional guidelines
EducationSelf-management strategies

The Avandia Flap (pages 35-36)

Charles A. Reasner, M.D.

The Editor reviews the salient points of the recent commotion over rosiglitazone and offers a possible solution that would avert similar problems in the future.
Drug treatmentThiazolidinediones